Reduced resistance can occur when cancer cells become more susceptible to treatment due to genetic changes or modifications in their environment. For instance, specific mutations may render cancer cells more vulnerable to certain drugs. Additionally, changes in the [tumor microenvironment](href) such as reduced hypoxia or decreased levels of protective proteins like P-glycoprotein can also contribute to reduced resistance.
